Hjem › Bløddelssarkom › New York
Bløddelssarkom kliniske forsøg i New York
27 studier for Bløddelssarkom søger deltagere på steder i New York.
Byer i New York
- New York City19 studier
- Queens9 studier
- Greenburgh7 studier
- Staten Island6 studier
- New Rochelle6 studier
- The Bronx3 studier
Officiel studietekst (engelsk)
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06942442Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069A Study of CRD3874-SI in People With Solid Tumors
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- og 1 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT06021626First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06797999Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1
Alder 12 til 85 · Alle køn · Opdateret 8. sep. 2026 · NCT03715933Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- New York University Langone Health, New York
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT05732831Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT04577014First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06644755Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Montefiore Medical Center, The Bronx
RekruttererFase 1/2
Alder 12 til 40 · Alle køn · Opdateret 3. sep. 2026 · NCT07725380A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- og 1 flere
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT05837767Actinium Therapy for Late-stage Aggressive Sarcomas
- Memorial Sloane Kettering Cancer Center, New York
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT07156565STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- Northwell Health Cancer Institute, Lake Success
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT06975293Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- Roswell Park Cancer Institute, Buffalo
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 21. aug. 2026 · NCT03965234A Study of MGC026 in Participants With Advanced Solid Tumors
- START-New York Long Island, Lake Success
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT06242470Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- Memorial Sloan Kettering Commack (Consent and Follow-Up), Commack
- Memorial Sloan Kettering Westchester (Consent and Followup), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- og 1 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 30. jul. 2026 · NCT00579566A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
- Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- og 1 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. jul. 2026 · NCT07089992Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
- Zai Lab Site 02002, New York
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. jul. 2026 · NCT07374848Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 19 til 110 · Alle køn · Opdateret 29. jun. 2026 · NCT02012699Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
- og 1 flere
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 15. maj 2026 · NCT06129903A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
- Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- og 1 flere
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 23. apr. 2026 · NCT04332874Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
- Roswell Park Comprehensive Cancer Center, Buffalo
RekruttererObservationsstudie
Alder 12 til 70 · Alle køn · Opdateret 15. apr. 2026 · NCT07402577A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
- Memorial Sloan Kettering Cancer Centre, New York
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 12. mar. 2026 · NCT05755113Phase II Trial of Lung Chemoemobolization
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 5. mar. 2026 · NCT05672108Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
- New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
RekruttererFase 1/2
12 Months – 40 Years · Alle køn · Opdateret 5. feb. 2026 · NCT03465592Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1/2
Alder 2 til 30 · Alle køn · Opdateret 3. feb. 2026 · NCT05734066A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital at Montefiore, The Bronx
RekruttererFase 2
18 Months – 40 Years · Alle køn · Opdateret 12. aug. 2025 · NCT05135975A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Memorial Sloan-Kettering Cancer Center, New York
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 25. nov. 2024 · NCT05824975Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.